Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-23-000015 General Corporate
Debt relative to revenue 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
145.06% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.29% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.21% · OPTIONAL · VALID
Revenue growth 95th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
14.87% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
74.58% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.86% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.30% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.24% · OPTIONAL · VALID
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.60% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 166.96%
Current 145.06%
Delta -21.90% Capex Intensity Decreased
Previous 1.70%
Current 1.29%
Delta -0.41% Cash Generation Increased
Previous 15.75%
Current 20.21%
Delta 4.46% Growth Decreased
Previous 15.60%
Current 14.87%
Delta -0.72% Inventory Pressure Decreased
Previous 77.46%
Current 74.58%
Delta -2.88% Margin Increased
Previous 36.85%
Current 38.86%
Delta 2.01% Profitability Increased
Previous 16.01%
Current 18.30%
Delta 2.29% R And D Intensity Increased
Previous 2.87%
Current 3.24%
Delta 0.37% Sbc Intensity Increased
Previous 0.52%
Current 0.60%
Delta 0.08% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.